Xpert® MTB/RIF
Accurate Detection of MTB and Rifampin Resistance Mutations
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
Unit price
Product is not available for purchase in your region.
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • Each day, more than 3,400 people lose their lives to TB and nearly 30,000 people fall ill with this preventable and curable disease1
  • In the United States, 22% of people affected by TB are still not diagnosed by the WHO-recommended rapid diagnostic test1
  • Precise and early detection of TB is needed to improve case management and significantly enhance the prevention of TB transmission2
1 Global Tuberculosis Report 2023. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023. Accessed Jan 2024.
2 Centers for Disease Control and Prevention—Guidelines for preventing the transmission of TB-- https://www.cdc.gov/mmwr/preview/mmwrhtml/00001897.htm. Accessed Jan 2024.

The Solution

The Xpert MTB/RIF test provides fast and accurate detection of Mycobacterium Tuberculosis (MTB) and Rifampicin (RIF) resistance simultaneously from patient samples
  • Simple three-step process with results in less than 2 hours
  • Designed to provide the most accurate MTB and Rifampicin detection
  • On-demand capability that empowers physicians to manage patients effectively

The Impact

  • Early detection of MTB and resistance to Rifampicin enables faster access to the most appropriate treatment for better patient outcomes3
  • Significantly reduces AII (airborne infection isolation) duration compared to the smear microscopy3
  • Implementation is highly cost-effective for diagnosing pulmonary TB in the United States4
3 Christopher K. Lippincott et al, Xpert MTB/RIF Assay Shortens Airborne Isolation for Hospitalized Patients With Presumptive Tuberculosis in the United States Clin Infect Dis. 2014 Jul 15; 59(2): 186–19

4 H. W. Choi, et al, Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States Int J Tuberc Lung Dis. 2013 October ; 17(10): 1328–1335